Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetic
100%
Barbiturate
94%
Fluorescence Assay
94%
Vancomycin
94%
Bipolar Disorder
94%
Infection
81%
Diseases
71%
Tumor Growth
63%
Inflammation
62%
Barbituric Acid
60%
Normal Human
55%
Sodium Valproate
55%
Antiinflammatory Agent
54%
Sustained Release
53%
High Performance Liquid Chromatography
52%
Malignant Neoplasm
49%
Candida Meningitis
47%
Cohort Study
47%
Superoxide
47%
Pyrazole Derivative
47%
Multidrug Resistance
47%
HIV
47%
Coronavirinae
47%
Protein Binding
47%
Paclitaxel
47%
Tumor Model
47%
Gold Nanoparticle
47%
Nonnucleoside Reverse Transcriptase Inhibitor
47%
Mosapride
47%
Pharmaceutics
47%
Diclofenac
47%
Ascorbic Acid
47%
Rheumatoid Arthritis
47%
Inflammatory Arthritis
47%
Barbital
47%
Collagen-Induced Arthritis
47%
Delavirdine
47%
Pharmacodynamic Modeling
47%
Biliary Excretion
47%
Metabolic Disorder
47%
Tablet
47%
Human Immunodeficiency Virus Infection
47%
Cortisone
47%
Tacrolimus
47%
Mycophenolic Acid
47%
Nemonoxacin
47%
Lipophilicity
47%
Prevalence
47%
Proteinase Inhibitor
47%
Constitutive Androstane Receptor
47%
Keyphrases
High-performance Liquid Chromatography Method
54%
Rat Bile
47%
Single-tablet Regimen
47%
Aqueous Dispersion
47%
Colistin Sulfate
47%
Temporary Mechanical Circulatory Support
47%
Fluorescence Detection
47%
Cross-reactivity
47%
Buformin
47%
In Vivo Absorption
47%
Taiwan
47%
Non-viral Gene Delivery
47%
Optimal Experimental Design
47%
HPLC-fluorescence
47%
Mosapride
47%
Rat Plasma
47%
Isolated Perfused Rat Liver
47%
Excretion Kinetics
47%
Magnesium Ascorbyl Phosphate
47%
High Prevalence
47%
Barbituric Acid
47%
Membrane Permeability
47%
Biopharmaceutics Classification System
47%
Biowaiver
47%
Capillary Electrophoresis with Laser-induced Fluorescence Detection (CE-LIF)
47%
Norfloxacin
47%
Immediate Release Tablets
47%
Skin Delivery
47%
Chitosan Gel
47%
Palmitoyl-CoA
47%
Glycol chitosan
47%
ABCB1 Polymorphism
47%
Tissue Binding
47%
Barbital
47%
ATP Binding Cassette Subfamily B Member 1 (ABCB1)
47%
UV Detection
47%
HPLC-FLD
47%
MRI Contrast Agent
47%
Dose Duration
47%
Pharmacokinetic-pharmacodynamic Modeling
47%
Metabolic Disturbances
47%
Bipolar Disorder
47%
Vancomycin
47%
Diclofenac Sodium
47%
Oral Formulation
47%
Delavirdine
47%
High Risk
47%
DNA Conjugation
47%
Nanoparticle Conjugate
47%
Biological Strategies
47%